256 related articles for article (PubMed ID: 21723752)
1. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease.
Shingleton WB; Sewell PE
J Urol; 2002 Mar; 167(3):1268-70. PubMed ID: 11832711
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
4. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
Wessendorf J; König A; Heers H; Mahnken AH
Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
Park BK; Kim CK; Park SY; Shen SH
Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors.
Pautler SE; Pavlovich CP; Mikityansky I; Drachenberg DE; Choyke PL; Linehan WM; Wood BJ; Walther MM
Can J Urol; 2001 Aug; 8(4):1330-3. PubMed ID: 11564277
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
9. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
[TBL] [Abstract][Full Text] [Related]
10. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
11. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous cryoablation of masses in a solitary kidney.
Weisbrod AJ; Atwell TD; Frank I; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
AJR Am J Roentgenol; 2010 Jun; 194(6):1620-5. PubMed ID: 20489104
[TBL] [Abstract][Full Text] [Related]
13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
18. Cryoablation vs. radiofrequency ablation for small renal masses.
Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
[TBL] [Abstract][Full Text] [Related]
20. [Conservative therapy by percutaneous radiofrequency ablation of renal cell carcinomas--therapeutic experiments of four patients with seven renal tumors--].
Karashima T; Inoue K; Shimamoto T; Yamasaki I; Kamada M; Shuin T
Hinyokika Kiyo; 2006 Apr; 52(4):241-7. PubMed ID: 16686349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
